Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer

Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer

Procollagen-Lysine,2-Oxoglutarate 5-Dioxygenase 3 (PLOD3) is related to a variety of human diseases. However, its function in Colorectal cancer (CRC) remains uncertain. PLOD3 expression was analyzed using The Cancer Genome Atlas (TCGA) pan-cancer data. DAVID was used for enrichment analysis of PLOD3...

Full description

Bibliographic Details
Main Authors: Junhong Shi, Meiyu Bao, Weifeng Wang, Xuan Wu, Yueying Li, Changdong Zhao, Weiwei Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
Colorectal cancer
PLOD3
biomarker
prognosis
immune therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.722807/full

Similar Items

Similar Items